BIEI - Premier Biomedical Inc. (OTC: BIEI) Welcomes Officers Directors and Key Advisors
(NewsDirect)
McapMediaWire --Premier Biomedical Inc., now known as Premier Graphene, Inc. (OTC: BIEI ), has relocated its headquarters to Imperial Valley, CA.CEO Ivan Mendez welcomes its new officers, directors, and othersignificant participants.
As Vice President, Noe Gallego will spearhead ourMexico hemp procurement operations. Mr. Gallego shared the following,“I am excited to be at the forefront of a rapidly growing industry,with a talented group of persons involved in Premier Graphene, Inc.(Premier). Premier is uniquely poised to revolutionize a variety ofindustrial sectors from health and wellness to aerospace andconstruction. With the aid of its counsel in Mexico, Premier GrapheneInc will permit low-cost and robust growing operations to supplyhigh-quality hemp as the principal raw material component forproducing the highest-quality graphene that is eco-friendly. Perhapsironically, it will also inevitably be at a more accessible cost.Indeed, it will be particularly well-suited for Premier’s wide rangeof products. Perhaps equally important, the environment in Mexicopermits 3 Growth cycles per year for this type of industrial hemp,which is the highest quality and best-suited for high-grade grapheneproduction.”
Chief of Legal Operations in Mexico and Latin America, AnaErika Santana, Esq., presently is assisting the federal government ofMexico to codify cannabis and hemp laws and to enact appropriateregulations consistent with such initiatives. Ms. Santana specializesin compliance within both the corporate and government sectors. Ms.Santana added, “To have a successful business, we must have fullcompliance and cooperation among governmental bodies. I will alsoensure conformity with social responsibility which is particularlyimportant within this sector. My strong connections with the Mexicangovernment prompt my participation with Premier Graphene and create myoptimism for its future.”
Dr. George Stantchev, will serve as a scientificconsultant to Premier. Dr. Stantchev is the owner of four Europeancompanies that have a presence in North America. The first company,AEMC Technologies, is principally focused on thermal night visionunits for military and commercial use. It also engages in product andbusiness management consulting for medical imaging, defense imaging,consumer, automotive, industrial computing, and wirelesscommunications. Next is COMERG. It employs top-notch engineering forthe development of medicinal grade extracts and AG technologyspecialized equipment and machinery.
Dr. Stantchev is also the founder of DIAMAGNETIX, atech innovation company, specializing in improving key processes inthe development of Bio and Energy in a nano-material state. His lastcompany, Pure 5 Extractions Systems, is a leading innovative botanicalextraction company, with a specific focus on hemp and cannabis. Dr.Stantchev has worked on product development and manufacturing projectswith Fortune 500 companies. Ivan Mendez added that “I have had thegreat pleasure of knowing and working with George for 5 years, in theCannabis medicinal use field, George will be able to help us withWorldwide resource allocation and client-oriented multi-countryproduct development and manufacturing. I find him to be a greatscientist and a leader in the cannabis and hemp extraction businessworldwide. He has a brilliant mind and is willing to help when hecan.”
Dr.Richard Goulding, Chief Medical Officer, will be pursuing thedevelopment of medical applications for graphene. This includes uniqueand extremely efficacious applications for medical instrumentation.Dr. Goulding stated that “my colleagues will be assisting me indeveloping applications for medical research and development utilizingthe unique prospect of graphene involved in fluid filtrationprocesses.”
CFOand Human Resources officer, Yvonne Gallego stated, “I am excitedabout the potential of this rapidly growing industry and theopportunities it lends to financial growth, quality products, andinnovation. I am enthusiastic about leading a business that promotessustainability and environmental stewardship through the cultivationand use of this versatile crop to be employed in our grapheneproduction.”
“I believe Mrs. Gallego will be a valuable asset to ourcompany just as she was at HGI Pharma Inc.” states CEO IvanMendez.
JoshRockwell, VP of Pulp and Paper Division. “I am excited to joinPremier Graphene Inc. as VP of the Pulp and Paper Division. I am achemical engineer from the University of New Hampshire with 25 yearsof innovating in the pulp and paper industry through continuousimprovement. Hemp will revolutionize the way paper and other vitalmaterials are made. I am proud to join this talented team”. “I amconfident Josh’s role in Premier Graphene Inc. His vast experiencewill prove invaluable to our path forward” added CEO IvanMendez.
ChiefOperating Officer, Mark Kingston, will oversee the day-to-dayoperations and some of the product development. He will interface withBiographene Technology, 10% owned by Premier, to assure a sufficientquantity of high-grade graphene manufacturing. Mr. Kingston added,“As the Chief Operating Officer of US Hemp Hurd and founder ofPyrotech US Inc., I bring a wealth of experience in managing andminimizing operational risks, ensuring regulatory compliance, andbuilding relationships with stakeholders, customers, suppliers, andpartners”.
Leveraging his industrial engineering background, Mr. Kingstonwill drive key innovation and enhance efficiency to ensure thatPremier remains at the forefront of R&D, market awareness, anddelivery of commercial products and systems. “We are confident thatMark's contributions will play a crucial role in the success ofour organization,” says senior consultant Pedro “Pete”Mendez.
Pedro“Pete” Mendez, senior consultant to the Board, industrial hemp andcannabis researcher, and entrepreneur, specializing in acquisitionsand cannabis products. As a former project manager for HGI PharmaInc., Mr. Mendez stated: “I believe we will become the dominantforce in quality graphene production (for all uses) in North America.We have assembled a unique team. We are fostering innovativetechnology, manufacturing, and creating a new supply chain that we cancontrol, we will be disrupting the mined graphite market”.
CEO Ivan Mendez states:“We are still in the process of interviewing two candidates forChief Technology officer. We will be providing that information andsome very exciting updates as they occur.
See below links concerning theabove-identified persons and associated entities:
http://www.pure5extraction.com/
To get the latestnews on the exciting developments from Premier Biomedical Inc. (OTC:BIEI), now known as Premier Graphene, Inc., subscribe by submittingto:
https://premiergrapheneinc.com/contact/
For moreinformation, please contact us at: info@premiergrapheneinc.com
Website (work inprocess): https://premiergrapheneinc.com
Twitter:@PremierBiomedic
About PremierGraphene, Inc. (OTC: BIEI ),engaged in a holding company reorganization so that the parentcompany, renamed from “Premier Biomedical Inc.”, has almost noconvertible debentures (less than $20,000) outstanding. As a result,the successor issuer public company, Premier Graphene, Inc., hasnearly no debt. The predecessor issuer’s debt remains in theoriginal company, now a subsidiary of the publicly traded company. TheCompany is traded on the OTC Market, in full compliance with OTCMarket reporting requirements. Premier Graphene, Inc. is in theprocess of a single corporate action – changing its name with FINRAand thus OTC Markets. Its articles of incorporation prohibit a reversesplit. It is involved in the development of sophisticated productsutilizing the unique characteristics of graphene, partnering withvarious related corporations and unrelated corporations.
Safe HarborNotice
Certain statements contained herein are “forward-lookingstatements” (as defined in the Private Securities Litigation ReformAct of 1995). The Company’ cautions our readers that statements, andassumptions made in this news release constitute forward-lookingstatements and makes no guarantee of future performance.Forward-looking statements are based on estimates and opinions ofmanagement at the time the statements are made. These statements mayaddress issues that involve significant risks, uncertainties andassociated estimates made by management. Actual results could differmaterially from current projections or implied results. PremierGraphene, Inc. (OTC: BIEI ),whose name is being changed from Premier Biomedical Inc., undertakesno obligation to revise these statements following the date of thisnews release.
Contact Details
Premier Graphene, Inc.
Copyright (c) 2023 TheNewswire - All rights reserved.